Viewing Study NCT02218021



Ignite Creation Date: 2024-05-06 @ 3:10 AM
Last Modification Date: 2024-10-26 @ 11:29 AM
Study NCT ID: NCT02218021
Status: COMPLETED
Last Update Posted: 2014-12-02
First Post: 2014-08-14

Brief Title: A Study of the Abuse Liability Potential of Samidorphan in Healthy Non-Dependent Recreational Opioid Users
Sponsor: Alkermes Inc
Organization: Alkermes Inc

Study Overview

Official Title: A Randomized Double-Blind Placebo- and Positive-Controlled Crossover Study to Evaluate the Abuse Potential and Safety of Orally Administered Samidorphan in Non-Dependent Recreational Opioid Users
Status: COMPLETED
Status Verified Date: 2014-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the abuse potential and safety of samidorphan in healthy non-dependent adult recreational opioid users
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None